BioCentury
ARTICLE | Company News

Topotarget cancer news

April 12, 2010 7:00 AM UTC

TopoTarget reduced headcount by eight (17%) to 40, with the cuts including CFO Tim Corcoran, COO Steven Butcher and members of the company's research and preclinical development organization. The company expects the reductions to generate annual savings of about DKK6-DKK7 million ($1.1-$1.3 million) starting next year. At Dec. 31, 2009, the company reported DKK130.1 million ($25.2 million) in cash and a 12-month operating loss of DKK132.5 million ($25.7 million). ...